Antimicrobial utilisation reports


The National Antimicrobial Utilisation Surveillance Program (NAUSP) collects data from over 220 major Australian Hospitals and provides reports of key antibiotic usage rates.

In addition to annual reports, NAUSP publishes a number of other regular reports on Antimicrobial usage in Australian public and private hospitals. These are available here for download in pdf format.

Annual reports

Detailed NAUSP annual reports are produced showing usage of an expanded number of antimicrobials both nationally and in individual Australian public and private hospitals in a de-identified manner.

2016 NAUSP Annual Report (PDF 6.3MB)

2017 Antimicrobial use in South Australian hospitals

2017-2018 NAUSP Biennial report

Supplement: NAUSP 2017-2018 Biennial Report

COVID-19

Please note that some usage rates have fluctuated widely during the January to June 2020 reporting period. OBDs dropped markedly for some hospitals in some months, with consequential increases in reported usage rates. Usage rates should be interpreted with caution as they reflect the quantity of antimicrobials distributed or dispensed from pharmacy and not actual consumption at patient level. 

Benchmarking reports by peer group (total hospital and intensive care)

January 2020 to June 2020 

These six-monthly reports enable contributors to compare their usage against other similarly-peered hospitals. Private hospitals are assigned by NAUSP to an AIHW peer group appropriate to their size and acuity.

Principal referral hospitals and specialist women's, de-identified - total hospital use (PDF 390KB)

Principal referral hospitals, de-identified - Intensive Care Unit usage (PDF 314KB)

Public acute group A hospitals, de-identified - Intensive Care Unit usage (PDF 88KB)

Public acute group A hospitals, de-identified  total hospital usage (PDF 395KB)

Public acute group B hospitals, de-identified - total hospital usage (PDF 87KB)

Public acute group C hospitals, de-identified - total hospital usage (PDF 84KB)

Benchmarking reports by state

January 2020 to June 2020 

These six-monthly reports allow contributors to compare their usage with other hospitals within their state or territory.

New South Wales and Australian Capital Territory with hospital data de-identified (PDF 91KB)

Queensland and Northern Territory with hospital data de-identified (PDF 88KB)

South Australia with hospital data de-identified (PDF 85KB)

Victoria with hospital data de-identified (PDF 89KB)

Western Australia with hospital data de-identified (PDF 87KB)

National aggregated reports by peer group

January 2020 to June 2020

These reports include aggregated usage by all contributors, or all contributors within an acute hospital peer group, for both total hospital use and intensive care unit (ICU) use.

All contributing hospitals (PDF 947KB)

Principal referral hospitals (PDF 952KB)

Public acute group A hospitals (PDF 961KB)

National speciality reports

January 2020 to June 2020

For hospitals able to submit usage data at the specialty level, these reports provide aggregated usage rates for the following specialties:

Haematology / Oncology (PDF 588KB)

High Dependency Unit (PDF 542KB)

Intensive Care Unit (PDF 566KB)

Respiratory (PDF 504KB)

Statewide aggregated reports

January 2020 to June 2020 

Statewide reports show aggregated antimicrobial usage data at a state level.

New South Wales and Australian Capital Territory (PDF 634KB)

Queensland and Northern Territory (PDF 638KB)

South Australia (PDF 644KB)

Victoria (PDF 622KB)

Western Australia (PDF 649KB)

Contributor reports from the NAUSP portal

Hospitals contributing to NAUSP can download reports directly from the online NAUSP portal showing usage rates for their individual hospitals. These contain charts comparing the individual hospital’s usage compared to the average usage at similarly peered hospitals. Hospitals that contribute usage data for particular specialties can access usage reports for Intensive Care Unit, haematology/oncology, high dependency unit and respiratory ward specialities in their hospitals.

Disclaimer

Usage rates reported in previously published NAUSP reports may differ from current reports. The Defined Daily Dose (DDD) values for some commonly used antimicrobials were changed by the WHO in January 2019. Due to these changes, usage rates in more recently published reports may not be directly comparable with prior reports that utilised the former DDD values for the analysis. In addition to amendments to WHO DDDs, rates may differ as a result of retrospective data adjustments or varying numbers of hospitals contributing to aggregated data.

Acknowledgement

The Australian Commission on Safety and Quality in Health Care provides funding for the administration of NAUSP and the analyses of NAUSP data and related reports for the AURA Surveillance System.

Citation

Unless otherwise stated within a report, please attribute the reports found on this webpage (and any material sourced from them) using the following citation:

National Antimicrobial Utilisation Surveillance Program. [insert report title]. Adelaide: SA Health; [insert year of publication].

Further reading

Further information

For further information on National Antimicrobial Utilisation Surveillance Program, contact the Program Coordinator at Health.NAUSPhelp@sa.gov.au.

Follow us on Twitter https://twitter.com/NAUSP_au